![](/img/cover-not-exists.png)
A study of the circulating fibroblast growth factor 21 as a novel noninvasive biomarker of hepatic injury in genotype-4 chronic hepatitis C: Egyptian patients and their response to direct-acting antiviral agents
El Sagheer, Ghada, Ahmad, Asmaa, Abd-ElFattah, Aliaa, Saad, Zienab, Hamdi, LamiaVolume:
Volume 11
Language:
english
Journal:
Clinical and Experimental Gastroenterology
DOI:
10.2147/CEG.S173484
Date:
October, 2018
File:
PDF, 1.00 MB
english, 2018